2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4391 | 2020 |
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index EK Speliotes, CJ Willer, SI Berndt, KL Monda, G Thorleifsson, AU Jackson, ... Nature genetics 42 (11), 937-948, 2010 | 3543 | 2010 |
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular … Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ... European heart journal 34 (39), 3035-3087, 2013 | 2374 | 2013 |
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis BF Voight, LJ Scott, V Steinthorsdottir, AP Morris, C Dina, RP Welch, ... Nature genetics 42 (7), 579-589, 2010 | 2176 | 2010 |
Variation in FTO contributes to childhood obesity and severe adult obesity C Dina, D Meyre, S Gallina, E Durand, A Körner, P Jacobson, ... Nature genetics 39 (6), 724-726, 2007 | 1958 | 2007 |
Severe hypoglycemia and risks of vascular events and death S Zoungas, A Patel, J Chalmers, BE De Galan, Q Li, L Billot, M Woodward, ... New England Journal of Medicine 363 (15), 1410-1418, 2010 | 1755 | 2010 |
Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding … M Marre, J Shaw, M Brändle, WMW Bebakar, NA Kamaruddin, J Strand, ... Diabetic Medicine 26 (3), 268-278, 2009 | 1147 | 2009 |
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ... Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009 | 1130 | 2009 |
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution IM Heid, AU Jackson, JC Randall, TW Winkler, L Qi, V Steinthorsdottir, ... Nature genetics 42 (11), 949-960, 2010 | 1106 | 2010 |
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 824 | 2014 |
Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations D Meyre, J Delplanque, JC Chèvre, C Lecoeur, S Lobbens, S Gallina, ... Nature genetics 41 (2), 157-159, 2009 | 765 | 2009 |
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 722 | 2017 |
A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk N Bouatia-Naji, A Bonnefond, C Cavalcanti-Proença, T Sparsø, ... Nature genetics 41 (1), 89-94, 2009 | 693 | 2009 |
Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications M Marre, P Bernadet, Y Gallois, F Savagner, TT Guyene, M Hallab, ... Diabetes 43 (3), 384-388, 1994 | 553 | 1994 |
Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia J Rung, S Cauchi, A Albrechtsen, L Shen, G Rocheleau, ... Nature genetics 41 (10), 1110-1115, 2009 | 550 | 2009 |
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, ... Diabetologia 57, 2465-2474, 2014 | 531 | 2014 |
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. M Marre, G Chatellier, H Leblanc, TT Guyene, J Menard, P Passa British Medical Journal 297 (6656), 1092-1095, 1988 | 510 | 1988 |
Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events K Franklin, RJ Goldberg, F Spencer, W Klein, A Budaj, D Brieger, M Marre, ... Archives of Internal Medicine 164 (13), 1457-1463, 2004 | 487 | 2004 |
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1 … S Heller, J Buse, M Fisher, S Garg, M Marre, L Merker, E Renard, ... The Lancet 379 (9825), 1489-1497, 2012 | 473 | 2012 |
Metformin use and mortality among patients with diabetes and atherothrombosis R Roussel, F Travert, B Pasquet, PWF Wilson, SC Smith, S Goto, ... Archives of internal medicine 170 (21), 1892-1899, 2010 | 454 | 2010 |